United States News Todas as matérias

Dynagas LNG Partners (NYSE:DLNG) reported a 27.9% increase in first-quarter net income, driven by robust vessel operations and stable fixed-term employment across its maritime liquefied natural gas shipping assets.

The Bank of Nova Scotia (Scotiabank) (NYSE:BNS) has signed a definitive agreement to acquire Maple Financial Holdings, the parent company of MapleMark Bank, a U.S. commercial bank based in Dallas, Texas. Financial terms of the transaction were not immediately disclosed.

Elmet Group (NASDAQ:ELMT) reported a 20.7% increase in first-quarter revenue, propelled by expanding volumes in its core aerospace, defense, and government end markets.

Ondas (NASDAQ:ONDS) secured more than $30 million in new contracts during May 2026, pushing its total second-quarter orders to date beyond $110 million.

HomesToLife (NASDAQ:HTLM) reported a 36% increase in first-quarter net profit, driven by accelerating export demand and expanding gross margins that counterbalanced an uptick in operating costs and foreign currency headwinds.

Tempus AI (NASDAQ:TEM) announced that the U.S. Food and Drug Administration (FDA) has granted approval for a tumor-only indication for its xT CDx next-generation sequencing platform.

Johnson & Johnson (NYSE:JNJ) reported positive late-stage clinical data for its blood cancer therapy Tecvayli (teclistamab-cqyv), demonstrating significant improvements in survival metrics for patients with relapsed or refractory multiple myeloma.

Bristol Myers Squibb (NYSE:BMY) announced positive late-breaking results from its Phase 3 SUCCESSOR-2 clinical trial, demonstrating that its experimental oral therapy mezigdomide significantly extends the time patients with relapsed or refractory multiple myeloma live without their disease worsening.

Best Buy (NYSE:BBY) announced that its Board of Directors has authorized the payment of a regular quarterly cash dividend of $0.96 per common share, maintaining the electronics retailer's commitment to its ongoing capital return program.

CoStar Group (NASDAQ:CSGP) has entered into a definitive agreement to acquire Zonda, a prominent provider of new home construction data, homebuilder software, and residential marketplaces, for $800 million in cash.

Pfizer (NYSE:PFE) announced unprecedented seven-year follow-up results from its Phase 3 CROWN trial, revealing that its oncology drug Lorbrena significantly extended progression-free survival in patients with a specific, aggressive form of lung cancer.

AbbVie (NYSE:ABBV) has secured authorization from the European Commission for an expanded label of its oncology drug VENCLYXTO (venetoclax) to treat adult patients with previously untreated chronic lymphocytic leukemia (CLL).

Lowe’s Companies (NYSE:LOW) authorized a 4% increase to its quarterly cash dividend, extending a multi-decade track record of annual payout increases and signaling confidence in its steady cash generation capabilities.

Agios Pharmaceuticals (NASDAQ:AGIO) announced that it will discontinue the clinical development of its investigational oral therapy tebapivat for lower-risk myelodysplastic syndromes (LR-MDS) after a Phase 2b study failed to meet its predefined threshold for advancement.

CollPlant Biotechnologies (NASDAQ:CLGN) initiated a formal review of its strategic alternatives after a sharp contraction in milestone revenue caused its first-quarter sales to drop to near-zero, forcing the company to slash its workforce by half.

The Buckle (NYSE:BKE) reported a significant increase in first-quarter profitability, driven by steady brick-and-mortar sales growth and an injection of cash from a finalized legal settlement.

International Flavors & Fragrances (NYSE:IFF) agreed to sell its Food Ingredients division to funds advised by CVC Capital Partners in a transaction valuing the unit at approximately $4.3 billion.

Genesco (NYSE:GCO) reported first-quarter revenue that surpassed Wall Street expectations, driven by a modest recovery in brick-and-mortar retail traffic that countered stagnant growth across its e-commerce segments.

Merck (NYSE:MRK) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to its investigational oral drug calderasib when paired with the company’s blockbuster immunotherapy Keytruda, accelerating its development path for newly diagnosed lung cancer patients.

Noah Holdings (NYSE:NOAH) reported a sharp acceleration in operating profitability for the first quarter of 2026, as a structural rebound in domestic wealth management clients and stringent cost controls offset flat revenues and equity asset volatility.

Chagee Holdings (NASDAQ:CHA) reported a rise in first-quarter revenue as aggressive international expansion partially offset cooling demand in its home market, though a sharp contraction in operating margins drove net income down by more than a third.

Natera (NASDAQ:TRA) has entered into a clinical collaboration with Diakonos Oncology to deploy its liquid biopsy technology to track patient responses during an active trial for an aggressive skin cancer therapy.

BeOne Medicines (NASDAQ:ONC) is moving to advance the treatment paradigm for chronic lymphocytic leukemia (CLL) with extensive long-term follow-up data slated for the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

Shares of Dell Technologies (NYSE:DELL) soared nearly 40% in premarket trading on Friday after robust demand for its Nvidia-powered artificial intelligence servers prompted the hardware giant to sharply raise its annual revenue and profit forecasts.